Record grant will allow Denmark’s BioInnovation Institute to scale up support for life science and deep tech innovation
Photo credits: BioInnovation Institute
The chief executive of Denmark’s BioInnovation Institute says a record grant from the Novo Nordisk Foundation will allow it to scale up its support for life science and biotech start-ups, and to further expand into AI and quantum.
Earlier this month, the Novo Nordisk Foundation pledged up to DKK 5.5 billion (€736 million) to the institute from 2026 to 2035, the largest grant ever awarded by the foundation to a single recipient. It is also a significant increase on its previous commitment of €470 million from 2021 to 2030.
“The new grant follows a thorough evaluation of the BioInnovation Institute’s impact and is seen as a natural next step to build on its proven track record and support its expansion into new areas and geographies,” said a Novo Nordisk Foundation spokesperson.
The foundation, one of the world's leading funders of pharmaceutical and biotech research and the controlling shareholder in Novo Nordisk, launched the BioInnovation Institute in 2018. It…
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.